| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.081 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |